Facts you should know about Tamiflu

Tamiflu is a prescription medicine used to treat the flu (influenza) in people 2 weeks of age and older who have had flu symptoms for no more than 2 days. Tamiflu can also reduce the chance of getting the flu in people 1 year and older.

Tamiflu does not prevent bacterial infections that may happen with the flu.

Tamiflu is not recommended for people with end-stage renal disease (ESRD) who are not receiving dialysis.

Tamiflu is not a substitute for an annual flu vaccination.

Do not take Tamiflu if you are allergic to oseltamivir phosphate or any of the ingredients in Tamiflu.

Important Safety Information

If you have an allergic reaction or a severe rash with Tamiflu, stop taking it and contact your doctor right away. This may be very serious

People with the flu, particularly children and adolescents may be at an increased risk of seizure, confusion, or abnormal behaviour early during their illness

Let your doctor know if you are pregnant, nursing, have heart problems, breathing problems, a weakened immune system (immunocompromised), kidney problems or other medical conditions as Tamiflu may not be right for you

Also, tell your doctor about any medications you are taking or if you’ve received a nasal-spray flu vaccine in the past two weeks

The most common side effects are nausea, vomiting, headache and pain

Please see the Tamiflu full Prescribing Information for complete important safety information.

ABOUT TARCEVA 150MG TABLETS 

TARCEVA is targeted therapy. Tarceva is classified as an epidermal growth factor receptor (EGFR) inhibitor – protein-tyrosine kinase inhibitor. It works by helping to stop cancer cells from growing. 

ERLOTINIB 150MG TABLETS USES : 

Tarceva medicine is used for : 
    Treatment of patients with locally advanced or metastatic non-small cell lung cancer (NSCLC).
    Treatment of patients with locally advanced, unresectable or metastatic pancreatic cancer.
Erlotinib 150mg Tablets works by slowing cancer cell growth. It binds to a certain protein (epidermal growth factor receptor-EGFR) in some tumors. 

TARCEVA COMMON SIDE EFFECTS :

Nausea, vomiting, loss of appetite, mouth sores, dry skin, eye dryness/irritation, or unusual eyelash growth may occur. Changes in diet such as eating several small meals or limiting activity may help lessen the chance of nausea. If any of these effects persist or worsen, notify your doctor or pharmacist promptly. 

Tell your doctor right away if any of these rare but very serious side effects occur: signs of kidney problems (such as change in the amount of urine), black stools, vomit that looks like coffee grounds, easy bleeding/bruising, stomach/abdominal pain, yellowing eyes or skin, dark urine, unusual fatigue, signs of infection (e.g., fever, chills, persistent sore throat), eye pain, vision changes. 

This is not a complete list of possible side effects. If you notice other effects not listed above, contact your doctor or pharmacist.

Generic Tarceva TabletsPrecautions : 

·        Before using this
medication, tell your doctor or pharmacist your medical history, especially of:
previous cancer treatments (including radiation therapy to the chest), heart
disease, high blood pressure, a previous severe reaction to monoclonal antibody
treatment.

·        
Perjeta can make
you more likely to get infections or may worsen any current infection. Avoid contact
with people who have infections that may spread to others (such as chickenpox,
measles, flu). Consult your doctor if you have been exposed to an infection or
for more details.

·        
Do not have
immunizations/vaccinations without the consent of your doctor. Avoid contact
with people who have recently received live vaccines (such as flu vaccine
inhaled through the nose).

·        
Tell your doctor
if you are pregnant or plan to become pregnant. You should not become pregnant
while using Pertuzumab. This medication may harm an unborn baby.

·        
It is unknown if
this medication passes into breast milk. Because of the possible risk to the
infant, breast-feeding is not recommended while using this drug or for 7 months
after the last dose. Consult your doctor before breast-feeding.

PROPER STORAGE OF TARCEVA TABLETS :

Store at 25°C (77°F); excursions are permitted between 15°C and 30°C (59°F and 86°F).

ERLOTINIB TABLETS INTERACTIONS :

Some products that may interact with this drug include:

    “blood thinners” (e.g., warfarin)
    corticosteroids (such as prednisone)
    drugs that lower stomach acid (some examples are H2 blockers such as famotidine/ranitidine, proton pump inhibitors such as omeprazole)
    drugs affecting liver enzymes that remove erlotinib from your body (such as azole antifungals, including itraconazole; macrolide antibiotics, including erythromycin; cimetidine; rifamycins, including rifabutin; St. John’s wort; certain anti-seizure medicines, including carbamazepine; HIV protease inhibitors, including ritonavir)
    MAO inhibitors (isocarboxazid, linezolid, methylene blue, moclobemide, phenelzine, procarbazine, rasagiline, selegiline, tranylcypromine)

Cigarette smoking decreases blood levels of this medication. Tell your doctor if you smoke or if you have recently stopped smoking.

This document does not contain all possible drug interactions. Keep a list of all the products you use (including prescription/nonprescription drugs and herbal products) and share it with your doctor and pharmacist.

WHAT IS TASIGNA 150 MG TABLET? 

Nilotinib is a type of biological therapy called a protein tyrosine kinase inhibitor (TKI). Tyrosine kinases are proteins that act as chemical messengers (enzymes). They can stimulate cancer cells to grow. Nilotinib blocks a tyrosine kinase protein called Bcr-Abl. The protein is made by chronic myeloid leukaemia cells that have an abnormal chromosome called the Philadelphia chromosome. Blocking this protein stops the leukaemia cells growing. 95 out of 100 people with CML (95%) have the Philadelphia chromosome. 

USES OF TASIGNA TABLETS: 

Nilotinib is used to treat a type of blood cancer called Philadelphia chromosome positive chronic myeloid leukemia (CML). Nilotinib is usually given after other medications have been tried without success. 

Tasigna 150 mg Capsule is used in the treatment of blood cancer (Chronic myeloid leukaemia). It is used in patients whose disease could not be treated with other medications for leukaemia or who cannot take these medications.

POSSIBLE SIDE EFFECTS: 

This medication decreases bone marrow function, an effect that may lead to a low number of blood cells such as red cells, white cells, and platelets. This effect can cause anemia, decrease your body’s ability to fight an infection, or cause easy bruising/bleeding. Tell your doctor right away if you develop any of the following serious symptoms: severe tiredness, pale skin, signs of infection (such as fever, chills, persistent sore throat), easy bruising/bleeding (such as bloody/black stool, bloody/pink urine). 

COMMON SIDE EFFECTS MAY INCLUDE:

Nilotinib sometimes causes side effects due to the rapid destruction of cancer cells (tumor lysis syndrome). To lower your risk, your doctor may add a medication and tell you to drink plenty of fluids. Tell your doctor right away if you have symptoms such as: low back/side pain (flank pain), signs of kidney problems (such as painful urination, change in the amount of urine), muscle spasms/weakness.

Rash, itching, nausea, vomiting, diarrhea, constipation, heartburn, gas, loss of appetite, headache, dizziness, tiredness, difficulty falling asleep or staying asleep, night sweats, muscle cramps, back, bone, joint, limb, or muscle pain, hair loss, dry or reddened skin, numbness, burning, or tingling in the hands or feet.

DRUGS INTERACTIONS: 

Drug interactions may change how your medications work or increase your risk for serious side effects. This document does not contain all possible drug interactions. Keep a list of all the products you use (including prescription/non-prescription drugs and herbal products) and share it with your doctor and pharmacist. Does not start, stop, or change the dosage of any medicines without your doctor’s approval.

Many drugs besides nilotinib may affect the heart rhythm (QT prolongation), including amiodarone, dofetilide, pimozide, procainamide, quinidine, sotalol, macrolide antibiotics (such as erythromycin), among others.

DRUGS PRECAUTIONS:

Before taking nilotinib, tell your doctor or pharmacist if you are allergic to it; or to lactose/galactose; or if you have any other allergies. This product may contain inactive ingredients, which can cause allergic reactions or other problems. Talk to your pharmacist for more details. 

Nilotinib may cause a condition that affects the heart rhythm (QT prolongation). QT prolongation can rarely cause serious (rarely fatal) fast/irregular heartbeat and other symptoms (such as severe dizziness, fainting) that need medical attention right away.